Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Reprogramming Stem Cells to Attack Cancer Cells

Reprogramming Stem Cells to Attack Cancer Cells

The immune system has particularly specialized cells called invariant natural killer T cells (iNKT) . Although very rare in the body, they are more powerful than other immune cells. In September 2019, Cell Stem Cell published a study in which a method enabling invariant natural killer T cells to attack cancer cells more effectively was discovered. When these cells were used in mouse models with different cancers, tumor growth was suppressed.

Invariant natural killer T cells (iNKT) are promising for cancer treatment because they target multiple cancer cells simultaneously. However, humans have very few of these cells. They account for less than 0.1% of all blood cells. Some previous clinical studies found longer survival in patients with higher iNKT levels.

An advantage of this approach is that it is a one-time cell treatment that may provide patients with iNKT cells for life.

Researchers aimed to develop a permanent treatment enabling the body to produce more iNKT cells. They first used hematopoietic stem cells , normally found in bone marrow and capable of developing into all blood and immune cells. By modifying stem cells through genetic engineering, researchers successfully converted them into iNKT cells.

Invariant natural killer T cells obtained through hematopoietic stem cell engineering were transplanted into mouse cells carrying human cancer cells (myeloma and melanoma). Increased iNKT cell numbers and cessation of tumor growth were observed in mice.

What Does This Study Mean for Us?

  • Further research is needed to determine whether stem cell-derived iNKT cells benefit human cancer treatment and to understand their long-term side effects.
  • The most exciting aspect is that a single treatment sends very large numbers of iNKT cells to fight cancer and may remain active for a long time.

Sources

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Reprogramming Stem Cells to Attack Cancer Cells

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy